GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.360
-0.250 (-9.58%)
At close: Mar 20, 2026, 4:00 PM EDT
2.400
+0.040 (1.69%)
After-hours: Mar 20, 2026, 7:11 PM EDT

GRI Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3372939
Market Cap Growth
-4.28%-53.52%326.67%-79.99%-77.69%-
Enterprise Value
-4.753.457.47-0.079.2731.34
Last Close Price
2.366.91394.2416674.56376849.207770890.40
PE Ratio
--0.06-0.26-0.12-2.44-2730.00
PB Ratio
0.200.571.846.70-5.336.68
P/TBV Ratio
38.56112.91640.155973.59-4.83736.51
P/FCF Ratio
--0.34-0.86-0.19-7.97-4.67
P/OCF Ratio
--0.34-0.86-0.19-7.99-4.67
EV/EBITDA Ratio
--0.29-0.910.01-4.15-3.41
EV/EBIT Ratio
--0.29-0.910.01-4.14-3.39
EV/FCF Ratio
--0.34-0.870.01-8.52-3.77
Debt / Equity Ratio
0.000.000.020-0.380
Debt / EBITDA Ratio
-0.01-0.01-0.010.00-0.30-
Debt / FCF Ratio
0.00-0.01-0.010.00-0.62-
Net Debt / Equity Ratio
0.010.010.03-6.93-0.41-1.29
Net Debt / EBITDA Ratio
-0.01-0.01-0.010.16-0.300.82
Net Debt / FCF Ratio
0.00-0.01-0.010.20-0.610.90
Quick Ratio
-000.670.003.07
Current Ratio
-001.090.163.32
Return on Equity (ROE)
-238.17%-238.17%-382.52%1908.78%-153.45%-426.35%
Return on Assets (ROA)
---557.17%-682.06%-51.36%-199.33%
Return on Invested Capital (ROIC)
--1075.07%915.35%180.64%673.38%
Return on Capital Employed (ROCE)
559.80%559.80%1196.08%1684.47%-104.65%-400.82%
Earnings Yield
-350.59%-1762.56%-392.03%-842.64%-40.96%-0.04%
FCF Yield
-298.77%-296.26%-116.38%-518.87%-12.55%-21.39%
Buyback Yield / Dilution
-452.39%-452.39%-187.37%-707.09%1.43%-39.90%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q